title: Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity.
authors.affiliation: Neuro-Urology, Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland. areitz@balgrist.unizh.ch
authors.forename: Andre
authors.initials: A
authors.lastname: Reitz
authors.forename: Brigitte
authors.initials: B
authors.lastname: Schurch
mesh_terms: D000328:Adult; D001905:Botulinum Toxins / Q000008:administration & dosage*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007267:Injections; D008666:Metalloendopeptidases / Q000008:administration & dosage*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: C096323:rimabotulinumtoxinB; D008666:Metalloendopeptidases; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A